# Vertex Pharmaceuticals Incorporated (VRTX) Vertex Pharmaceuticals (VRTX) reports strong Q4 earnings with revenue up 10% and provides optimistic [----] guidance, while Casgevy sales show accelerated uptake, driving positive sentiment. ### About Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals is a biopharmaceutical company focused on developing medicines for serious diseases. Vertex Pharmaceuticals Incorporated uses the ticker $VRTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Vertex Pharmaceuticals Incorporated (VRTX) trading volume is up 75.26% from the previous week. - Vertex Pharmaceuticals Incorporated (VRTX) social dominance is up 292.06% from the previous week. - Vertex Pharmaceuticals Incorporated (VRTX) Galaxy Score™ is up 35.9% from the previous week. - Vertex Pharmaceuticals Incorporated (VRTX) sentiment is up 41.94% from the previous week. - Vertex Pharmaceuticals Incorporated (VRTX) engagements is up 244.92% from the previous week. - Vertex Pharmaceuticals Incorporated (VRTX) mentions is up 46.24% from the previous month. - Vertex Pharmaceuticals Incorporated (VRTX) posts created is up 120.75% from the previous week. ### Price: $491.50  [Price 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/close.tsv) Despite a recent dip, positive social sentiment, strong earnings reports, and analyst upgrades suggest a temporary dip before a potential increase. 24-Hour: 6.35% 7-Day: 3.26% 30-Day: 11.35% 1-Year High: $513.80 on 2025-03-17 1-Year Low: $366.50 on 2025-08-08 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/alt_rank.tsv) Vertex Pharmaceuticals Incorporated (VRTX) is currently AltRank #477 based on combined combined social and market metrics Daily Average: [---] [--] Week: [---] +405 [--] Month: [---] [----] [--] Months: [---] [---] [--] Year: [---] +147 1-Year High: [-----] on 2025-07-12 1-Year Low: [--] on 2025-05-31 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] +14 [--] Month: [--] [---] [--] Months: [--] [---] [--] Year: [--] +10 1-Year High: [--] on 2025-03-03 1-Year Low: [--] on 2025-09-14 ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/interactions.tsv) Current Value: [------] Daily Average: [------] [--] Week: [-------] +245% [--] Month: [-------] +85% [--] Months: [---------] -51% [--] Year: [----------] -43% 1-Year High: [-------] on 2025-08-05 1-Year Low: [-----] on 2025-12-26 Engagements by network (24h): Reddit: [--] TikTok: [--] YouTube: [--] X: [------] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/posts_active.tsv) Current Value: [---] Daily Average: [---] [--] Week: [---] +26% [--] Month: [-----] +46% [--] Months: [------] -13% [--] Year: [------] +8.50% 1-Year High: [---] on 2025-06-27 1-Year Low: [--] on 2025-12-21 Mentions by network (24h): Reddit: [--] TikTok: [--] YouTube: [--] X: [---] ### Creators: [---] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/contributors_active.tsv) [---] unique social accounts have posts mentioning Vertex Pharmaceuticals Incorporated (VRTX) in the last [--] hours which is down 0.84% from [---] in the previous [--] hours Daily Average: [---] [--] Week: [---] +7.10% [--] Month: [---] +35% [--] Months: [-----] +2.30% [--] Year: [-----] +59% 1-Year High: [---] on 2025-06-27 1-Year Low: [--] on 2025-12-21 The most influential creators that mention Vertex Pharmaceuticals Incorporated in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@OracleEarnings](/creator/twitter/OracleEarnings) | [--] | [------] | [--] | [---] | | [@semodough](/creator/twitter/semodough) | [--] | [------] | [--] | [---] | | [@RNAiAnalyst](/creator/twitter/RNAiAnalyst) | [--] | [------] | [--] | [---] | | [@WJones_Global](/creator/twitter/WJones_Global) | [--] | [---] | [--] | [---] | | [@AIStockSavvy](/creator/twitter/AIStockSavvy) | [--] | [------] | [--] | [---] | | [@tenet_research](/creator/twitter/tenet_research) | [--] | [-------] | [--] | [---] | | [@doepke_michel](/creator/twitter/doepke_michel) | [--] | [-----] | [--] | [---] | | [@somoscdi](/creator/twitter/somoscdi) | [--] | [------] | [--] | [---] | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | [--] | [-----] | [--] | [---] | | [@HedgeFundTips](/creator/twitter/HedgeFundTips) | [--] | [------] | [--] | [---] | [View More](/list/creators/vertex-pharma/100) ### Sentiment: 72%  [Sentiment 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/sentiment.tsv) Current Value: 72% Daily Average: 71% [--] Week: 88% +26% [--] Month: 61% -6% [--] Months: 61% -9% [--] Year: 61% -18% 1-Year High: 97% on 2025-07-18 1-Year Low: 44% on 2025-05-03 Most Supportive Themes: - Bullish Sentiment and Price Predictions: (45%) Users are expressing optimism about VRTX's future performance and predicting price increases. - Positive News and Partnerships: (25%) Recent developments such as reimbursement agreements and new collaborations are contributing to positive sentiment. - Technical Analysis and Chart Patterns: (15%) Analysis of VRTX's stock chart indicates bullish patterns, suggesting a potential upward trend. Most Critical Themes: - Market Volatility: (10%) General concerns about the broader market's fluctuations and potential price corrections are present. - Token Closure Concerns: (5%) Some discussion revolves around the closure of a token, leading to negative sentiment. ### Social Dominance: 0.03%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/social_dominance.tsv) Current Value: 0.03% Daily Average: 0.047% [--] Week: 0.025% +0.018% [--] Month: 0.056% +0.027% [--] Months: 0.056% -0.0051% [--] Year: 0.056% -0.027% 1-Year High: 0.136% on 2025-03-12 1-Year Low: 0.015% on 2025-12-21 ### Market Dominance: 0.142%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/market_dominance.tsv) Current Value: 0.142% Daily Average: 4% 1-Year High: 5.60% on 2026-02-06 1-Year Low: 0.142% on 2026-02-14 ### Market Cap: $125,479,413,406  [Market Cap 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/market_cap.tsv) Current Value: $125,479,413,406 Daily Average: $114,185,675,807 [--] Week: $125,479,413,406 +4.10% [--] Month: $124,695,193,872 +11% [--] Months: $124,695,193,872 +24% [--] Year: $124,695,193,872 +5.80% 1-Year High: $131,932,122,793 on 2025-03-17 1-Year Low: $93,977,429,218 on 2025-08-08 ### Top Vertex Pharmaceuticals Incorporated Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications" [X Link](https://x.com/PharmaAlerts/status/2022744046763151640) [@PharmaAlerts](/creator/x/PharmaAlerts) 2026-02-14T18:45Z [---] followers, [---] engagements "$MSTR 126% wild spike from bottom entry $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ https://t.co/VxP7hrHqe0 $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT" [X Link](https://x.com/sMoontrade/status/2022733806747423150) [@sMoontrade](/creator/x/sMoontrade) 2026-02-14T18:04Z [---] followers, [---] engagements "forward p/e 2/13 yahoo finance $FIX [-----] $FTAI [-----] $STT [-----] $TDY [-----] $Q [-----] $NVT [-----] $ENTG [-----] $MTSI [-----] $AKAM [-----] $KRMN [------] $NVMI [-----] $DY [-----] $SOLS [-----] $VRTX [-----] $MOD [-----] $STRL [-----] $AEIS [-----] $SWKS [-----] $QRVO [-----] $POWL 38.31" [X Link](https://x.com/yukkeyo/status/2022687846872814072) [@yukkeyo](/creator/x/yukkeyo) 2026-02-14T15:02Z [---] followers, [---] engagements "If I am right and the new $RIG can generate $3B of annual free cash flow in a base case and $46B in an optimistic case a rerating is possible. There are not many companies in the world that can produce that level of free cash flow. Look at $UBER $AMT $AMD $VRTX $MMM. They trade between $90B and $300B market caps. But offshore is hated. It cannot get premium multiples. I think that is fine. On the Q3 [----] earnings call the CFO said: Once leverage is reduced management intends to return capital primarily through share repurchases rather than dividends. A lower multiple means they can buy back" [X Link](https://x.com/cannibalstocks/status/2022570081058713951) [@cannibalstocks](/creator/x/cannibalstocks) 2026-02-14T07:14Z [---] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Vertex Pharmaceuticals (VRTX) reports strong Q4 earnings with revenue up 10% and provides optimistic [----] guidance, while Casgevy sales show accelerated uptake, driving positive sentiment.
Vertex Pharmaceuticals is a biopharmaceutical company focused on developing medicines for serious diseases.
Vertex Pharmaceuticals Incorporated uses the ticker $VRTX for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
Despite a recent dip, positive social sentiment, strong earnings reports, and analyst upgrades suggest a temporary dip before a potential increase.
24-Hour: 6.35% 7-Day: 3.26% 30-Day: 11.35%
1-Year High: $513.80 on 2025-03-17
1-Year Low: $366.50 on 2025-08-08
AltRank 24-Hour Time-Series Raw Data
Vertex Pharmaceuticals Incorporated (VRTX) is currently AltRank #477 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +405
[--] Month: [---] [----]
[--] Months: [---] [---]
[--] Year: [---] +147
1-Year High: [-----] on 2025-07-12
1-Year Low: [--] on 2025-05-31
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +14
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] +10
1-Year High: [--] on 2025-03-03
1-Year Low: [--] on 2025-09-14
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +245%
[--] Month: [-------] +85%
[--] Months: [---------] -51%
[--] Year: [----------] -43%
1-Year High: [-------] on 2025-08-05
1-Year Low: [-----] on 2025-12-26
Engagements by network (24h): Reddit: [--] TikTok: [--] YouTube: [--] X: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +26%
[--] Month: [-----] +46%
[--] Months: [------] -13%
[--] Year: [------] +8.50%
1-Year High: [---] on 2025-06-27
1-Year Low: [--] on 2025-12-21
Mentions by network (24h): Reddit: [--] TikTok: [--] YouTube: [--] X: [---]
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Vertex Pharmaceuticals Incorporated (VRTX) in the last [--] hours which is down 0.84% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +7.10%
[--] Month: [---] +35%
[--] Months: [-----] +2.30%
[--] Year: [-----] +59%
1-Year High: [---] on 2025-06-27
1-Year Low: [--] on 2025-12-21
The most influential creators that mention Vertex Pharmaceuticals Incorporated in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @OracleEarnings | [--] | [------] | [--] | [---] |
| @semodough | [--] | [------] | [--] | [---] |
| @RNAiAnalyst | [--] | [------] | [--] | [---] |
| @WJones_Global | [--] | [---] | [--] | [---] |
| @AIStockSavvy | [--] | [------] | [--] | [---] |
| @tenet_research | [--] | [-------] | [--] | [---] |
| @doepke_michel | [--] | [-----] | [--] | [---] |
| @somoscdi | [--] | [------] | [--] | [---] |
| @MarcJacksonLA | [--] | [-----] | [--] | [---] |
| @HedgeFundTips | [--] | [------] | [--] | [---] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 72%
Daily Average: 71%
[--] Week: 88% +26%
[--] Month: 61% -6%
[--] Months: 61% -9%
[--] Year: 61% -18%
1-Year High: 97% on 2025-07-18
1-Year Low: 44% on 2025-05-03
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.03%
Daily Average: 0.047%
[--] Week: 0.025% +0.018%
[--] Month: 0.056% +0.027%
[--] Months: 0.056% -0.0051%
[--] Year: 0.056% -0.027%
1-Year High: 0.136% on 2025-03-12
1-Year Low: 0.015% on 2025-12-21
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.142%
Daily Average: 4%
1-Year High: 5.60% on 2026-02-06
1-Year Low: 0.142% on 2026-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $125,479,413,406
Daily Average: $114,185,675,807
[--] Week: $125,479,413,406 +4.10%
[--] Month: $124,695,193,872 +11%
[--] Months: $124,695,193,872 +24%
[--] Year: $124,695,193,872 +5.80%
1-Year High: $131,932,122,793 on 2025-03-17
1-Year Low: $93,977,429,218 on 2025-08-08
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications"
X Link @PharmaAlerts 2026-02-14T18:45Z [---] followers, [---] engagements
"$MSTR 126% wild spike from bottom entry $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ https://t.co/VxP7hrHqe0 $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT"
X Link @sMoontrade 2026-02-14T18:04Z [---] followers, [---] engagements
"forward p/e 2/13 yahoo finance $FIX [-----] $FTAI [-----] $STT [-----] $TDY [-----] $Q [-----] $NVT [-----] $ENTG [-----] $MTSI [-----] $AKAM [-----] $KRMN [------] $NVMI [-----] $DY [-----] $SOLS [-----] $VRTX [-----] $MOD [-----] $STRL [-----] $AEIS [-----] $SWKS [-----] $QRVO [-----] $POWL 38.31"
X Link @yukkeyo 2026-02-14T15:02Z [---] followers, [---] engagements
"If I am right and the new $RIG can generate $3B of annual free cash flow in a base case and $46B in an optimistic case a rerating is possible. There are not many companies in the world that can produce that level of free cash flow. Look at $UBER $AMT $AMD $VRTX $MMM. They trade between $90B and $300B market caps. But offshore is hated. It cannot get premium multiples. I think that is fine. On the Q3 [----] earnings call the CFO said: Once leverage is reduced management intends to return capital primarily through share repurchases rather than dividends. A lower multiple means they can buy back"
X Link @cannibalstocks 2026-02-14T07:14Z [---] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/vertex-pharma